A study done by researchers from the New York University School of Medicine shows 18 percent lower risk of the development of peripheral artery disease (PAD) among individuals with the consumption of at least three pieces of fruit and vegetables per day when compared with those individuals who are consuming less. The researchers conducted studies among 3.7 million individuals and came to above conclusion.
The study shows individuals with peripheral artery disease (PAD) were 6.3 percent and individuals eating at least three servings of fruit and vegetables were 29.2 percent. This study shows the significance of consuming fruit and vegetables in reducing risk associated with peripheral artery disease (PAD). This study also confirms dismally low consumption of fruit and vegetables among citizens. Researchers observed a number of individuals consuming at least three servings of fruit and vegetables are more among older white women and least among younger black men.
Peripheral artery disease (PAD) limits the flow of oxygen-rich blood to the muscles by narrowing the leg arteries and causes difficulties and pains while standing or walking. Author of the study was Dr. Jeffrey Berger, an associate professor of medicine and surgery, the New York University School of Medicine and co-author of the study was Sean Heffron, the New York University School of Medicine. The study findings were published in the American Heart Association journal Arteriosclerosis, Thrombosis and Vascular Biology.
Israeli scientists from Sheba Medical Center and the Ben-Gurion University of the Negev have developed a new way to treat atherosclerosis and prevent stroke and heart diseases. They invented biomedical nano-polymer to fight stroke and heart diseases, which a is better treatment compared to statins. The newly developed biomedical nano-polymer reduces plaque formation in arteries and inflammation in the vascular system that transport bloodstream rich with oxygen and nutrients to organs, tissues and cells. The polymer prevents future plaque development and inflammation. Plaque formation in the arteries is a risk factor for diseases such as arterial thrombosis, myocardial infarction, ischemia and stroke. Advantages with biomedical nano-polymer are
The patented polymer therapy is under the pre-clinical stage. Experiments with mice models are positive. Scientists observed marked improvements in arteries of mice models injected with a new biomedical polymer. The thickness of the arteries was reduced and there was less inflammation. Scientists say the new polymer-based therapy can help individuals with hypertension, diabetes and other diseases associated with old age.
Dr. Ora Horovitz, senior vice president of business development at the BGN Technologies, the technology transfer company of the Ben-Gurion University of the Negev, says they are looking for a pharmaceutical company for the further development and marketing of the new polymer-based therapy.
Researchers from the University of Adelaide have developed a new type 2 diabetes (T2D) drug that works effectively in reducing blood sugar levels with reduced insulin injections. The new drug reduces blood sugar levels by acting at the molecular level by fully or partially activating PPARgamma protein receptor found in the fat tissues throughout the body. In this process, the drug increases insulin levels and changes in the metabolism of fat and sugar. The INT131 drug, the original version is currently under clinical trials in the United States. Later drug versions were improved further to treat type 2 diabetes condition. Lead researcher of the study was Dr. John B Bruning, Senior Lecturer, The University of Adelaide, Australia.
The Diabetes News Chronicle does not provide medical advice, diagnosis or treatment. Information in Diabetes News Chronicle is to support and not to replace medical advice given by the surgeon or physician or doctor. Published article is not a medical advice by the OWNER of "Diabetes News Chronicle" website or by the AUTHOR of the article.
Published by Jammi Vasista, Chennai, India.